Search results
Target says it's cutting back on Pride merchandise at some stores after backlash
CBS News· 14 minutes agoTarget is cutting back on the number of its stores that will cary Pride Month-related merchandise in...
Target to reduce number of stores carrying Pride-themed merchandise after last year's backlash
San Francisco Chronicle· 2 hours agoTarget, which operates roughly 2,000 stores, said Friday that the decision to offer Pride...
Target To Limit LGBTQ Merchandise In Stores For Pride Month:Report - Target (NYSE:TGT)
Benzinga· 55 minutes agoA Target spokeswoman stated that the company will provide a selection of Pride items in select...
Battered by boycott and backlash, Target to no longer sell Pride collection in all stores
Indianapolis Star via Yahoo News· 13 hours agoAdvocacy groups condemned Target for bowing to pressure. Target said this year it will carry adult...
Ichor (NASDAQ:ICHR) PT Lowered to $50.00
ETF DAILY NEWS· 6 hours agoIchor (NASDAQ:ICHR – Get Free Report) had its price target lowered by stock analysts at Craig Hallum from $55.00 to $50.00 in a research
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 hour agoArray delivered "solid" Q1 results and strong bookings while reiterating 2024 guidance, says the...
Paramount Global (NASDAQ:PARA) Stock Rating Upgraded by StockNews.com
ETF DAILY NEWS· 9 hours agoJPMorgan Chase & Co. reduced their price objective on Paramount Global from $13.00 to $12.00 and set...
Target to cut LGBTQ Pride month products from some stores after backlash, Bloomberg reports
MSN News· 13 hours ago(Reuters) - Target is planning to cut LGBTQ-themed merchandise from some of its stores during Pride...
Tech, Media & Telecom Roundup: Market Talk
The Wall Street Journal· 3 hours ago0704 GMT – AEM Holdings looks well-placed to ride on the growing system-level test market, DBS Group Research analysts say in a research report ...
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 30 minutes agoIn the first quarter, we continued to make significant advancements with our REZPEG...evaluating REZPEG in a Phase 2b study in moderate to severe atopic dermatitis, which started last year & ...
